Task Force Overview
From LipidomicsWiki
(Difference between revisions)
Line 1: | Line 1: | ||
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br> | The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br> | ||
- | |||
- | |||
- | |||
- | |||
== Overview of LipidomicNet Task Forces == | == Overview of LipidomicNet Task Forces == | ||
The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners. | The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners. | ||
- | |||
- | |||
- | |||
- | |||
{| class="prettytable FCK__ShowTableBorders" | {| class="prettytable FCK__ShowTableBorders" | ||
Line 79: | Line 71: | ||
| Clinical trials and human ethics | | Clinical trials and human ethics | ||
- | | [[User:Daniela Gasperikova|Daniela Gasperikova]] | + | | [[User:Daniela Gasperikova|Dr. Daniela Gasperikova]] |
- | | Karpe | + | | [[User:Frederik_Karpe|Dr. Fredrik Karpe]] |
| [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]] | | [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]] | ||
Line 109: | Line 101: | ||
| LipidomicNet-Bioinformatics | | LipidomicNet-Bioinformatics | ||
- | | [[User: | + | | [[User:Juan Antonio Vizcaíno|Dr. Juan_Antonio_Vizcaíno]] |
| [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]] | | [[User:Gerd Schmitz|Prof. Dr. Gerd Schmitz]] |
Revision as of 08:15, 21 July 2011
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.
Specific enabling technologies and their applications (TF I-IV).
Mouse models (TF V).
Human clinical trials and ethics issues (TF VI).
Translational research (TF VII).
LipidomicNet (TF VIII).
Dissemination and training (TF IX).
Overview of LipidomicNet Task Forces
The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.
Vertical Task Forces | Taskforce | chair | co-chair | Partner(s) |
---|---|---|---|---|
Task Force I | Mass-spectrometric and chromatographic methods andpreanalytics for molecular lipid species analyses and stable isotope labelling | Prof. Micheal Wakelam | PhD. Gerhard Liebisch | P01, P02, P04, P06, P07, P11, P13, P14, P15A, P15B, P17, P18, P19, P21, P22, P25 |
Task Force II | Fluorescence-based lipidomic methods on intact cells, labelling lipidomic antibodies and proteins | Dr. Christoph Thiele | Prof. Dr. Aldona Dembinska-Kiec | P01, P04, P09, P11, P13, P14, P15B, P23, P24 |
Task Force III | Affinity binder, ELISA and proteomic mass-spectrometric techniques and reagents | Dr. Stefan Müllner | Dr. Jens Hansen | P01, P07, P16, P20 |
Task Force IV | Gene-, Taqman- and Bead-array reagents and preanalytics (RNA/DNA, Agilent, Affymetrix, Illumina, ABI TLDAs etc) | Prof. Dr. Gerd Schmitz | Dr. Christian Wolfrum | P01, P06, P09 |
Task Force V | Mouse models | Dr. Christian Wolfrum | Van Dijk | P02, P03, P04, P05, P06, and P07 |
Task Force VI | Clinical trials and human ethics | Dr. Daniela Gasperikova | Dr. Fredrik Karpe | P01, P08, P09, P11, P12, P13, P14, P15A, P15B, 22, P23, and P24 |
Horizontal Task Forces | | | | |
Task Force VII | Human/Mouse translational research | Prof. Dr. Gerd Schmitz | Dr. Isabelle Dugail | P01, P04, P06, P12, P13, P15A |
Task Force VIII | LipidomicNet-Bioinformatics | Dr. Juan_Antonio_Vizcaíno | Prof. Dr. Gerd Schmitz | P01, P06, P10, P16, P17, P18, P21, P22, P25 |
Task Force IX | Dissemination, training and communication | Prof. Dr. Aldona Dembinska-Kiec | Dr. Megi Sharikadze | All partners |
Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.